Evolution of the inappropriate use of broad-spectrum antibiotics for Pseudomonas aeruginosa infections following the 2022 CA-SFM guidelines
{{output}}
Introduction: The European Committee on Antimicrobial Susceptibility Testing (EUCAST) changed the definition of the 'intermediate' (I) category in 2019, now defined as 'susceptible, increased exposure'. We previously reported... ...
